Detection of amyloid deposition in brain and heart using 11CPiBPET/CT imaging

Detection of amyloid deposition in brain and heart using 11CPiBPET/CT imaging - PiBPET/CT study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012320

Enrollment

105

Registered

2013-11-25

Start date

2010-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease and myocardial amyloidosis

Interventions

PET/CT imaging will be performed 50min after injection of 11CPiB, or dynamic imaging will be performed from the injection to 60 min.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suspected of Alzheimers disease and of cardiac amyloidosis, and those who have signed the informed consent form.

Exclusion criteria

Exclusion criteria: Those who have not signed the informed consent form. Those who are severe systemic condition with serious underlying disease, and may have a difficulty in completion of PET/CT examination. Those who have been decided not appropriate by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Positive predictive value	—

Secondary

Measure	Time frame
Sensitivity and specificity	—

Countries

Japan

Contacts

Public ContactRyogo Minamimoto

National Center for Global Health and Medicine Div.Nuclear Medicine, Dept.Radiology

rikensa@lily.ocn.ne.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026